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Stunning advances in the structural biology of multicomponent biomolecular complexes 12
(MBCs) have ushered in an era of intense, structure-guided mechanistic and functional 13 studies of these complexes. Nonetheless, existing methods to site-specifically conjugate 14
MBCs with biochemical and biophysical labels are notoriously impracticable and/or 15 significantly perturb MBC assembly and function. To overcome these limitations, we 16 have developed a general, multiplexed method in which we genomically encode non-17 canonical amino acids (ncAAs) into multiple, structure-informed, individual sites within a 18 target MBC; select for ncAA-containing MBC variants that assemble and function like the 19 wildtype MBC; and site-specifically conjugate biochemical or biophysical labels to these 20 ncAAs. As a proof-of-principle, we have used this method to generate unique single-21 molecule fluorescence resonance energy transfer (smFRET) signals reporting on 22 ribosome structural dynamics that have thus far remained inaccessible to smFRET 23 studies of translation. 24 25 Many fundamental cellular processes, including DNA repair, replication, transcription, 26 messenger RNA (mRNA) processing and splicing, nuclear export, mRNA decay, translation, 27 and protein degradation, are performed by MBCs. Continuing advances in X-ray crystallography 28 and, more recently, cryogenic electron microscopy (cryo-EM) studies of MBCs are providing 29 researchers with structural frameworks for most informatively positioning biochemical and 30 biophysical probes and interpreting the resulting biochemical and biophysical data in terms of 31 structure-based mechanistic models 1 . Unfortunately, however, it remains difficult and, in some 32 cases, impossible to site-specifically label MBCs at defined positions, severely impeding 33 mechanistic and functional studies. The primary reasons for this are that MBCs are composed 34 of up to thousands of oftentimes essential components, have tightly controlled component 35 stoichiometries, and are typically assembled through intricate and highly regulated assembly 36 pathways 2-4 . Consequently, common methods for site-specifically labeling proteins, such as conjugation of a maleimide-derivatized reporter to a cysteine residue, are impracticable for 38
MBCs that contain hundreds of native reactive residues 5 , while the peptide tags often used in 39 chemo-enzymatic labeling methods are usually limited to protein termini where they are least 40 likely to inhibit assembly and/or function 6, 7 . In addition, many labeling approaches involve 41 production of a target protein from a genetic construct (e.g., a plasmid) that removes the gene 42 from its native genomic regulatory context, and this can perturb the component stoichiometry 43 and/or cellular assembly process 8 . Attempts to overcome these issues by partially or fully in vitro 44 reconstituting MBCs from recombinantly overexpressed, purified, and labeled components often 45 results in compositionally and/or functionally heterogeneous MBC mixtures that exhibit impaired 46 activities 8 . 47
Here, we report an approach that integrates homologous recombination-based 48 multiplexed genome engineering (MGE) 9 , ncAA mutagenesis technology 10 , and bioorthogonal 49 chemistry 11 to rapidly generate numerous, fully functional MBC variants in which each variant 50 can carry a biochemical or biophysical label at one or more defined target positions. Our 51 approach combines the power of MGE to rapidly generate multiple, orthogonal codon mutations 52 ( Fig. 1a ) with the specificity and modularity of bioorthogonal ncAA-based conjugation chemistry, 53 while maintaining the genomic regulatory context, in vivo assembly pathway, and functional 54 integrity of the target MBC ( Fig. 1b-c ). Because ncAA mutations are much less perturbative than 55 peptide tag insertions and because small-molecule, chemistry-based conjugation is much less 56 sterically restricted than enzyme-based conjugation, our approach allows efficient labeling of 57 virtually any position in an MBC. Additionally, because our method requires that each strain 58 carrying a variant MBC effectively competes with the strain carrying the wild-type MBC, our 59 approach naturally counter-selects against variants that impair MBC function. Finally, the 60 abundance of biochemical and biophysical probes that have been derivatized for bioorthogonal 61 conjugation means that MBCs can be labeled with optical probes such as fluorophores and 62 quenchers, affinity tags such as biotin and digoxigenin, radioisotopes, spin-labels, chemical probing agents, crosslinking agents, solid-state supports, nanoparticles, microspheres, etc., for 64 use in a nearly endless array of biochemical and biophysical applications ( Fig. 1d ). 65
To demonstrate the power of our approach, we chose to target the Escherichia coli 66 ribosome -a 2.5 MDa, two-subunit MBC comprised of 55 ribosomal proteins and 3 ribosomal 67 RNAs (rRNAs). In bacteria, assembly and maturation of the ribosome is a complex process that 68 requires the action of ~100 cellular factors 2 . The importance of the genomic regulation and in 69 vivo assembly and maturation process of this MBC is highlighted by the observation that 70 ribosomes composed of a fully in vitro reconstituted small, or 30S, ribosomal subunit are only 34 71 % active compared to ribosomes composed of 30S subunits purified from cells 8 , a fact that has 72 complicated interpretation of biophysical studies performed using ribosomes composed of 30S 73 subunits that were site-specifically fluorophore-labeled via full in vitro reconstitution 12 . For site-74 specific labeling of the ribosome, we targeted thirteen different positions across nine ribosomal 75 protein genes (Table 1 , Supplementary Fig. 1 ), such that labeling with fluorophores at those 76 positions would enable smFRET studies of three ribosomal structural rearrangements that have 77 either been studied using smFRET signals that could not be interpreted unambiguously 13, 14 or 78 that have otherwise remained inaccessible to smFRET studies: (i) intra-subunit rotation of the 79 'head' domain of the 30S subunit relative to the 'body' domain (i.e., 'head swiveling', HS), (ii) 80 movement of a translating ribosome along its mRNA template (i.e., 'mRNA translocation', MT), 81 and (iii) rotation of the large, or 50S, ribosomal subunit relative to the 30S subunit (i.e., 82 'intersubunit rotation', IR) ( Supplementary Fig.1 ). 83
In order to site specifically label the E. coli ribosome at the selected thirteen positions, 84 we decided to genomically encode the ncAA p-azido-phenylalanine (p-AzF) using engineered 85 UAG stop codons that are typically decoded by polypeptide release factor (RF) 1 during 86 translation termination. The choice of p-AzF was driven by the fact that it undergoes a rapid and 87 robust, bioorthogonal conjugation reaction with dibenzocyclooctyne (DBCO)-derivatized 15 labels 88 under mild buffer and temperature conditions ( Fig. 1c ). To genomically encode p-AzF at 89 engineered UAG stop codons in a manner that was free of potential competition from RF1-90 mediated translation termination, we chose to use the C321ΔA strain of E. coli that has been 91 developed by Church and co-workers 16 (Methods). In C321ΔA, all 321 naturally occurring, 92 essential TAG stop codons in E. coli have been converted to TAA stop codons that are decoded 93 by RF2 and, moreover, the gene encoding RF1, prfA, has been deleted. Additionally, C321ΔA 94 carries a temperature-inducible lambda prophage for carrying out single-stranded, DNA-guided 95 homologous recombination (i.e., lambda Red (λRed)-mediated recombineering) 17 , thus allowing 96 MGE to be used to introduce codon mutations at the desired labeling positions. To tailor 97 C321ΔA for use with ribosomes, we disrupted the gene encoding RNase A 18-20 (Methods), and 98 to tailor it for p-AzF incorporation, we transformed it with a plasmid expressing an orthogonal 99 nonsense suppressor tRNA that recognizes UAG codons and a tRNA synthetase specific for 100 amino-acylating this tRNA with p-AzF 21, 22 (Methods). 101
Starting with our tailored C321ΔA strain, we performed six to eight rounds of λRed-102 mediated MGE using a multiplexed pool of oligonucleotides targeting the thirteen labeling sites 103 for mutation to TAG stop codons in the ribosomal protein genes in the E. coli genome 104 (Supplementary Table 1 ) (Methods). All rounds of MGE were performed in the presence of 1 105 mM p-AzF such that incorporation of the ncAA into the MBC occurs immediately upon 106 introduction of the mutation into the genome. The resulting cell population was screened using 107 multiplexed, allele-specific colony (MASC)-PCR 23 (Methods) such that we could identify strains 108 carrying the mutations as well as the position and nature of the mutations ( Supplementary Fig.  109 2). Once identified, the presence of mutations was further confirmed by Sanger sequencing 110 ( Supplementary Fig. 3 ). Using this approach, we were able to isolate ten strains in which each 111 strain carried either one or two TAG mutations at locations corresponding to ten of the thirteen 112 positions we originally targeted. We hypothesized that strains carrying TAG mutations at the 113 remaining three positions could not be isolated because these mutations conferred significant 114 fitness disadvantages. Supporting this hypothesis, the percent enrichment of mutation at each of the targeted positions ranged between two-to ten-fold lower than a mutation of a similar size 116 in a non-essential gene ( Table 1 ). These observations are consistent with our expectation that, 117 during the rounds of MGE, our approach selects for MBCs with functionally permissible 118
mutations. 119
To demonstrate that the isolated, mutant E. coli strains were able to assemble 120 ribosomes with site-specific incorporation of a p-AzF that can be efficiently labeled, we first 121 purified ribosomes from three double-mutant strains (HS1, HS2, and IR1), and one single-122 mutant strain (MT1) (Methods). To ensure high-efficiency labeling, we separated the purified 123 ribosomes into 30S and 50S subunits. The subunits were then labeled with DBCO-derivatized 124
Cy3 and/or Cy5 fluorophores (Methods). The ribosomal proteins from each subunit were 125 separated on an SDS-PAGE gel, and the gel was imaged using a fluorescence gel scanner 126 ( Fig. 2a ). In these scans, fluorescence was observed exclusively from bands corresponding to 127 ribosomal protein(s) whose gene(s) contained the TAG mutation(s). Moreover, fluorescence 128 scanning of an SDS-PAGE gel containing ribosomal proteins obtained from the 30S and 50S 129 subunits of a C321ΔA strain that did not contain any TAG mutations, but that was otherwise 130 grown in the presence of p-AzF and used to purify and fluorophore-label the 30S and 50S 131 subunits in a manner identical to that of the strains containing TAG mutations did not exhibit any 132 fluorescence. This observation demonstrates the site-specific nature of p-AzF incorporation into 133 the ribosomal proteins of the mutant strains ( Supplementary Fig. 4 ). To measure the labeling 134 efficiency of each labeled position, we quantified the fluorescence intensity of each labeled 135 protein band, and compared it to a standard curve generated using known quantities of a 136 fluorophore-labeled protein standard ( Supplementary Fig. 5 ) (Methods). We found that the 137 labeling efficiency was different for each targeted position, and ranged from a high of 96 % for 138 labeling at the aspartic acid at residue position 41 on the 30S subunit protein S6 (S6 D41) to a 139 low of 15 % for S7 G112 ( Supplementary Table 2 ). While it's possible that the lower labeling 140 efficiencies could be due to low p-AzF incorporation caused by background suppression of the 141 UAG mutation by near-cognate aa-tRNAs (e.g., Tyr-tRNA), such background suppression has 142 been found to be quite low in C321ΔA-based strains in presence of p-AzF 21 and we therefore 143 suspect it is more likely due to incomplete fluorophore labeling arising from the potentially low 144 solvent exposure of the targeted residue. Regardless of the origin of any low labeling efficiency, 145 because our approach uses MGE, it is easy to screen for another, comparable labeling position 146 with higher labeling efficiency. 147
To demonstrate the utility of our labeled ribosomes for smFRET studies, we performed 148 smFRET experiments using wide-field, total internal reflection fluorescence (TIRF) microscopy 149 (Methods). In these experiments, ribosomal complexes assembled on a 5'-biotinylated mRNA 150 using the Cy3 FRET donor-and/or Cy5 FRET acceptor-labeled ribosomes described above and 151 any required tRNAs and/or translation factors were tethered to the surface of a polyethylene 152 glycol (PEG)/biotin-PEG-derivatized quartz microfluidic flow-cell using a biotin-streptavidin-biotin 153 bridge ( Fig. 2b ). As previously described, tethered complexes were illuminated using the 154 evanescent wave generated by the 532 nm laser component of the TIRF microscope, and Cy3 155 and Cy5 fluorescence emissions from individual ribosomes were collected, wavelength 156 separated, and imaged using the optical and detector components of the TIRF microscope 24, 25 . 157
We imaged complexes harboring the HS1, MT1, and IR1 smFRET signals and, in each case, 158 we observed Cy3-and Cy5 florescence intensity versus time trajectories that exhibited anti-159 correlated Cy3 and Cy5 fluorescence intensity changes followed by single-step photobleaching 160 of the Cy3-and/or Cy5 fluorophore, demonstrating that the complexes contained single Cy3-161 and Cy5 fluorophores that were positioned so as to generate detectable FRET efficiencies 162 (EFRETs) (Fig. 2c ). For each complex, the EFRET versus time trajectories matched our 163 expectations regarding the EFRET values we observed and whether the trajectories remained at a 164 single EFRET value or fluctuated between multiple EFRET values as a function of time. Thus, the 165 new smFRET signals reported here can now be used for smFRET studies of ribosomal complex 166 dynamics that have heretofore remained difficult or impossible to interpret or perform due to the lack of a facile, versatile, and robust method for generating in vivo assembled, fully functional, 168 site-specifically labeled ribosomes. 169
In conclusion, we have demonstrated how a combination of MGE, ncAA mutagenesis 170 technology, and bioorthogonal chemistry can be used to label MBCs with biochemical or 171 biophysical probes without significantly perturbing the genomic regulation, in vivo assembly, 172 structure, or function of the MBCs. Our method is general, facile, versatile, and robust and can 173 therefore be used to site-specifically label any MBC at virtually any position with almost any type 174 of probe, enabling a wide array of biochemical and biophysical studies of MBCs. Moreover, 175
given recent advances in the use of MGE and ncAAs in other bacterial 26 
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ONLINE METHODS 285

Strains and Plasmids 286
The C321ΔA strain was a kind gift from George Church 16 . It is an E. coli MG1655 strain in which 287 all 321 naturally occurring essential TAG stop codons have been changed to TAA stop codons 288 and the gene encoding RF1, prfA, has been deleted. Its exact geneotype is: Δ(ybhB-289 bioAB)::[lcI857 N(cro-ea59)::tetR-bla] ΔprfA ΔmutS::zeoR. To render the C321ΔA strain RNase 290 A deficient, we performed four homologous recombination cycles using a mutagenic 291 oligonucleotide that targeted the ninth codon of the gene encoding RNAse A, rna, for mutation 292 to a TAA stop codon using a previously described method 9, 23 . Strains containing the analogous 293 mutation in rna are standard tools in biochemical and biophysical studies of ribosomes, 294 translation, and translational control 18-20 . The pEvol-pAzFRS.2.t1 plasmid encoding an 295 orthogonal nonsense suppressor tRNA that recognizes UAG codons and the tRNA synthetase 296 that specifically amino-acylates this tRNA with p-AzF was a kind gift from Farren Isaacs. 21 For 297 the experiments described here, we transformed the RNase A-deficient C321ΔA strain with 298 pEvol-pAzFRS.2.t1. 299 300
Multiplexed genome engineering cycles 301
Thirteen oligonucleotides targeting different codon sites in ribosomal protein genes for mutation 302 to TAG codons were designed as previously described 9, 23 , and purchased from Integrated DNA 303 Technologies Inc. ( Supplementary Table 1 ). MGE cycles were performed using the RNase A-304 deficient C321ΔA strain that had been transformed with the pEvol-pAzFRS.2.t1 plasmid and 305 following a previously published procedure 9, 23 . All of the media used for MGE contained 1 mM 306 p-AzF and 0.2 % arabinose. Cultures at the end of 6-8 MGE cycles were used to screen for 307 mutant strains using MASC-PCR (infra vide). If a double mutant was needed, as in the case of 308 generating the HS signals, one of the successfully engineered single-mutant strains was subjected to single-plexed genome engineering using the oligonucleotide targeting the second 310 successfully engineered position. 311 312 Screening for mutants and calculation of percent enrichment 313 MASC-PCR was used to screen for mutant strains in the pool of cells present in the culture after 314 6-8 MGE cycles, using previously published methods 9, 23 . Colonies that tested positive for 315 mutations in the MASC-PCR screening were sequenced by Sanger sequencing (Genewiz) in 316 order to confirm the presence and identity of the mutation. The percent enrichment of a 317 particular mutation was calculated by dividing the number of confirmed mutant colonies by the 318 total number of colonies screened and multiplying the result by 100. 319 320 Ribosome purification and labeling 321 70S ribosomes were purified using previously established procedures 30 with slight 322 modifications. 1 mL culture of C321ΔA wt or isolated mutant strain was used to inoculate 1L of 323 2´ Yeast Tryptone media (2´ YT) containing 1mM p-AzF, and 0.2 % arabinose. The culture was 324 grown to mid-log phase (OD 0.5), and the cells were harvested by centrifugation at 5000´g for 325 10 min. The actively translating 70S ribosomes and polysomes were then purified from the 326 harvested cells as previously described 30 . 327
In order to efficiently label the ribosomal subunits with DBCO-derivatized Cy3 and/or 328 Cy3-and Cy5-labled protein standards we used were L1 Q18C-Cy3 (L1 [Cy3]) and RF1 S167C-344 Cy5 (RF1 [Cy5]), respectively, that were isolated, labeled, and purified so as to exhibit 100 % 345
Cy3-or Cy5 labeling efficiencies as previously described 24, 31 ( Supplementary Fig. 4) . 346 347
Preparation of mRNAs, tRNAs, and translation factors 348
Ribosomal complexes for smFRET experiments using the HS and IR smFRET signals were 349 assembled on a previously described 32, 33 , 5'-biotinylated model mRNA that is a variant of the 350 mRNA encoding bacteriophage T4 gene product 32 (Bio-mRNA). Bio-mRNA was chemically 351 synthesized (IDT) ( Supplementary Table 3 ). Ribosomal complexes for smFRET experiments 352 using the MT smFRET signal were assembled on a previously described 30 , non-biotinylated 353 model mRNA consisting of the first twenty codons of bacteriophage T4 gene product 32 354 (NonBio-mRNA) that was hybridized to a previously described 30 , 5'-Cy5-labeled, 3'-biotinylated 355 DNA oligonucleotide (Cy5-DNA-Bio) ( Supplementary Table 3 ). NonBio-mRNA was synthesized 356 by in vitro transcription using bacteriophage T7 RNA polymerase, as previously described 25 , and 357
Cy5-DNA-Bio was chemically synthesized (IDT). Hybridization of NonBio-mRNA with Cy5-DNA-358
Bio was performed as previously described 25 . The hybridized NonBio-mRNA:Cy5-DNA-Bio was 359 purified away from excess, unhybridized Cy5-DNA-Bio using size-exclusion chromatography. E. coli initiator, formylmethionine-specific tRNA (tRNA fMet ) was purchased from MP Bio and was 361 aminoacylated and formylated using methionyl-tRNA synthetase and methionyl-tRNA 362 formyltranferase, respectively, using previously published procedures 30 . E. coli translation 363 initiation factors (IFs) 1, 2, and 3 were expressed and purified using established protocols as 364 described elsewhere 25 . 365 366
Preparation of ribosomal complexes for smFRET experiments 367
To perform smFRET experiments using the HS smFRET signal, we attempted to prepare a 30S 368 initiation complex (IC) similar to one that has been described as exhibiting HS dynamics in a 369 recent cryo-EM study by Ramakrishnan and co-workers 34 . To do this, we adapted general 370 protocols that we have previously developed for the preparation of 30S ICs 35, 36 . Specifically, we 371 incubated 0.6 μM 30S subunits labeled with Cy3 and Cy5 (30S HS1 [Cy3/Cy5]), 1.8 μM Bio-372 mRNA ( Supplementary Table 3 ), 0.9 μM fMet-tRNA fMet , 0.9 μM IF1, and 0.6 μM IF3 in Tris-373
Polymix Buffer (50 mM Tris-OAc at pHRT = 7.5, 100 mM KCl, 5 mM ammonium acetate 374 (NH4OAc), 5 mM Mg(OAc)2, 0.1 mM EDTA, 1 mM guanosine triphosphate (GTP), 5 mM 375 putrescine-HCl, 1 mM spermidine-free base, and 6 mM β-ME) for 10 minutes at 37 °C and 376 subsequently transferred the reaction to ice for an additional 5 minutes. The complexes were 377 divided into 1 μL aliquots and flash-frozen by immersing the tube in liquid nitrogen. The aliquots 378 were stored at -80 °C for future use 35, 36 . Given these reaction conditions, the fact that IF1 and 379 IF3 were maintained at 1 μM and 25 nM, respectively, in the buffers used throughout all 380 complex formation, dilution, tethering, and imaging steps (vide infra), and the results of previous 381 biochemical and smFRET work by us and others 32 , we expect this reaction to predominantly 382 yield the IF1-and IF3-containing 30S IC that is schematized on the left-hand panel of Figure 2b . 383
To perform smFRET experiments using the MT smFRET signal, we attempted to 384 prepare a 30S IC similar to one that has been described in a recent smFRET study by Gonzalez 385 and co-workers 32 , that would serve as a preliminary proof-of-concept model for MT signal. To do this, we again adapted general protocols that we have previously developed for the preparation 387 of 30S ICs 32, 35, 36 . Specifically, we incubated 0.6 μM 30S subunits labeled with Cy3 (30S MT1 388
[Cy3]), 1.8 μM NonBio-mRNA:Cy5-DNA-Bio ( Supplementary Table 3 ), 0.9 μM fMet-tRNA fMet , 0.9 389 μM IF1, and 0.9 μM IF2 in Tris-Polymix Buffer for 10 minutes at 37 °C and subsequently 390 transferred the reaction to ice for an additional 5 minutes. The complexes were divided into 1 μL 391 aliquots and flash-frozen by immersing the tubes in liquid nitrogen. The aliquots were stored at -392 80 °C for future use 35, 36 . Given these reaction conditions, the fact that IF1 and IF2 were 393 maintained at 1 μM and 25 nM, respectively, in the buffers used throughout all complex 394 formation, dilution, tethering, and imaging steps, and the results of previous smFRET studies 32 , 395 we expect this reaction to predominantly yield the IF1-, IF2-, and fMet-tRNA fMet -containing 30S 396 IC that is schematized on the center panel of Figure 2b . 397
To perform smFRET experiments using the IR smFRET signal, we attempted to prepare 398 a 70S pre-translocation complex mimic lacking a peptidyl-tRNA in the ribosomal aminoacyl-399 tRNA binding site (i.e., a 70S PRE -A complex) similar to one that has been described as 400 exhibiting IR dynamics in a previous smFRET study by Ha and co-workers 12 . To do this, we 401 adapted general protocols that we have previously developed for the non-enzymatic preparation 402 of 70S PRE -A complexes 33 . Specifically, we incubated 15 pmol 30S subunits labeled with Cy5 403 (30S IR1 [Cy5]), 30 pmol Bio-mRNA ( Supplementary Table 3 ), and 20 pmol deacylated tRNA fMet 404 in 30 μL of 70S PRE -A Assembly Buffer (50 mM Tris hydrochloride (Tris-HCl) at pHRT = 7.5, 70 405 mM NH4OAc, 30 mM KCl, 6 mM β-ME, and 7 mM MgCl2) for 10 minutes at 37 °C, at which 406 point 10 pmol 50S subunits labeled with Cy3 (50S IR1 [Cy3]) were added and the reaction 407 incubated for additional 20 minutes at 37 °C. The reaction was then placed on ice for 5 minutes 408 and diluted to a final volume of 100 μL with Tris-Polymix Buffer that had been adjusted to 20 409 mM Mg(OAc)2. The reaction was carefully layered on top of 10-40% (w/v) sucrose gradient 410 made in Tris-Polymix Buffer adjusted to 20 mM Mg(OAc)2 and purified by density gradient 411 ultracentrifugation as previously described 24, 33 . The complexes were divided into 25 μL aliquots and flash-frozen by immersing the tubes in liquid nitrogen. The aliquots were stored at -80 °C 413 for future use. Given these reaction conditions and the results of previous smFRET studies 33 , 414 we expect this reaction to predominantly yield the 70S PRE -A that is schematized on the right-415 hand panel of Figure 2b . Polymix Buffers that were used to dilute the complexes, but that had been further supplemented 427 with an oxygen-scavenging system (5 mM protocatechuic acid and 10 nM protocatechuate-3,4-428 dioxygenase) and a triplet state quencher (1 mM cyclooctatetraene). 429
The tethered complexes were then imaged using a laboratory-built, wide-field, prism-430 based TIRF microscope with a diode-pumped solid-state 532 nM laser (Laser Quantum 431 GEM532) as an excitation source for Cy3. Fluorescence emissions from Cy3 and Cy5 were 432 collected through a 60´ magnification, water-immersion objective with a numerical aperture of 
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